Psychiatry and Neurology, Neurology · San Antonio, TX
NPI
1407172521
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4402 Vance Jackson Rd Ste 146
San Antonio, TX, 78230
Phone (210) 962-5557
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
56,630 services
Medicare patients, 2024
179
Average age 70
Drug cost, 2024
$7.6M
2,476 prescriptions
Company payments, 2025
$1,798
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew W Wong was code J2919 (injection, methylprednisolone sodium succinate, 5 mg), 3,925 times for 13 patients. In total Andrew W Wong billed 56,630 services in 51 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 3,925 | 13 | $0.23 | $889 |
| 96366 Intravenous Infusion, Hydration | Office | 399 | 15 | $15.14 | $6,040 |
| 99214 Office E&M - Established | Office | 284 | 144 | $85.84 | $24K |
| 96365 Intravenous Infusion, Hydration | Office | 159 | 15 | $46.30 | $7,362 |
| 96375 Injection Administration | Office | 146 | 15 | $11.40 | $1,664 |
| 99204 Office E&M - New | Office | 38 | 38 | $119.18 | $4,529 |
| 95885 Electrical Nerve Conductivity | Office | 25 | 13 | $43.62 | $1,091 |
| 99215 Office E&M - Established | Office | 11 | 11 | $116.61 | $1,283 |
By year: 2022 $271K for 6,411 services; 2023 $1.4M for 18,523 services; 2024 $2.1M for 56,630 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew W Wong prescribed most often to Medicare patients was Sodium Chloride (0.9 % Sodium Chloride), with 202 prescriptions and refills. In total Andrew W Wong wrote 2,476 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sodium Chloride 0.9 % Sodium Chloride | 202 | 207 | 17 | $1,379 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 140 | 140 | Under 11 | $1.6M |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 123 | 123 | Under 11 | $1.4M |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 102 | 102 | Under 11 | $912K |
| Methylprednisolone Sodium Succ Methylprednisolone Sod Succ | 100 | 102 | Under 11 | $3,928 |
| Prednisone Generic | 89 | 123 | 27 | $783 |
| Ketorolac Tromethamine Generic | 83 | 83 | Under 11 | $353 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 70 | 70 | Under 11 | $1.5M |
| Pregabalin Generic | 62 | 88 | 14 | $1,677 |
| Levetiracetam Generic | 57 | 106 | 14 | $2,349 |
| Clonazepam Generic | 53 | 73 | Under 11 | $766 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 50 | 53 | Under 11 | $511K |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 49 | 49 | Under 11 | $509K |
| Gabapentin Generic | 44 | 54 | Under 11 | $348 |
| Dexamethasone Sodium Phosphate Generic | 42 | 42 | Under 11 | $124 |
Brand drugs: - claims; generic drugs: 1,558 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew W Wong $1,798 ($1,798 in general payments such as food, travel and fees) from 34 companies. The largest payer was UCB, Inc. with $168.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 9 | $168 |
| TG Therapeutics, Inc. TGTX | 11 | $159 |
| Royal Biologics, Inc. | 1 | $153 |
| Janssen Biotech, Inc. JNJ | 3 | $148 |
| Xeris Pharmaceuticals, Inc. | 4 | $88.62 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $83.42 |
| Argenx US, Inc. ARGX | 3 | $77.22 |
| Catalyst Pharmaceuticals, Inc. CPRX | 2 | $69.78 |
| Lundbeck LLC | 2 | $57.71 |
| Biogen, Inc. BIIB | 2 | $55.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.